Literature DB >> 15892904

An evaluation of persisting cognitive effects after withdrawal from long-term benzodiazepine use.

Melinda J Barker1, Kenneth M Greenwood, Martin Jackson, Simon F Crowe.   

Abstract

Twenty participants with self-reported long-term benzodiazepine use (mean 108 months) who had previously withdrawn from medication (mean 42 months) were administered a battery of neuropsychological tests. Each long-term user was case matched for age, sex, and education to two control participants who reported never taking benzodiazepines (those with and those without anxiety). The results indicated that long-term benzodiazepine use may lead to impairments in the areas of verbal memory, motor control/performance, and nonverbal memory but not visuospatial skills and attention/concentration. The length of abstinence (> 6 months) indicates that these impairments persist well beyond cessation of benzodiazepine use. However, observed impairments in the area of nonverbal memory were not solely attributable to benzodiazepine use and may be influenced by the elevated anxiety levels present in both the case and the anxious control group.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15892904     DOI: 10.1017/S1355617705050332

Source DB:  PubMed          Journal:  J Int Neuropsychol Soc        ISSN: 1355-6177            Impact factor:   2.892


  12 in total

1.  A quantitative meta-analysis of neurocognitive functioning in posttraumatic stress disorder.

Authors:  J Cobb Scott; Georg E Matt; Kristen M Wrocklage; Cassandra Crnich; Jessica Jordan; Steven M Southwick; John H Krystal; Brian C Schweinsburg
Journal:  Psychol Bull       Date:  2014-11-03       Impact factor: 17.737

2.  Benzodiazepines: good or bad medicine?

Authors:  Roger Ladouceur
Journal:  Can Fam Physician       Date:  2010-11       Impact factor: 3.275

Review 3.  Behavior at the choice point: decision making in hidden pathway maze learning.

Authors:  Elizabeth Thomas; Peter J Snyder; Robert H Pietrzak; Paul Maruff
Journal:  Neuropsychol Rev       Date:  2014-10-28       Impact factor: 7.444

4.  Effect of withdrawal from long-term use of temazepam, zopiclone or zolpidem as hypnotic agents on cognition in older adults.

Authors:  Juha Puustinen; Ritva Lähteenmäki; Päivi Polo-Kantola; Paula Salo; Tero Vahlberg; Alan Lyles; Pertti J Neuvonen; Markku Partinen; Ismo Räihä; Sirkka-Liisa Kivelä
Journal:  Eur J Clin Pharmacol       Date:  2013-12-12       Impact factor: 2.953

5.  Melatonin for sedative withdrawal in older patients with primary insomnia: a randomized double-blind placebo-controlled trial.

Authors:  Ritva Lähteenmäki; Juha Puustinen; Tero Vahlberg; Alan Lyles; Pertti J Neuvonen; Markku Partinen; Ismo Räihä; Sirkka-Liisa Kivelä
Journal:  Br J Clin Pharmacol       Date:  2014-06       Impact factor: 4.335

Review 6.  Canadian clinical practice guidelines for the management of anxiety, posttraumatic stress and obsessive-compulsive disorders.

Authors:  Martin A Katzman; Pierre Bleau; Pierre Blier; Pratap Chokka; Kevin Kjernisted; Michael Van Ameringen; Martin M Antony; Stéphane Bouchard; Alain Brunet; Martine Flament; Sophie Grigoriadis; Sandra Mendlowitz; Kieron O'Connor; Kiran Rabheru; Peggy M A Richter; Melisa Robichaud; John R Walker
Journal:  BMC Psychiatry       Date:  2014-07-02       Impact factor: 3.630

Review 7.  Persistent post-traumatic headache: a migrainous loop or not? The clinical evidence.

Authors:  Alejandro Labastida-Ramírez; Silvia Benemei; Maria Albanese; Antonina D'Amico; Giovanni Grillo; Oxana Grosu; Devrimsel Harika Ertem; Jasper Mecklenburg; Elena Petrovna Fedorova; Pavel Řehulka; Francesca Schiano di Cola; Javier Trigo Lopez; Nina Vashchenko; Antoinette MaassenVanDenBrink; Paolo Martelletti
Journal:  J Headache Pain       Date:  2020-05-24       Impact factor: 7.277

8.  Change in healthcare utilization and costs following initiation of benzodiazepine therapy for long-term treatment of generalized anxiety disorder: a retrospective cohort study.

Authors:  Ariel Berger; John Edelsberg; Michael Treglia; Jose Ma J Alvir; Gerry Oster
Journal:  BMC Psychiatry       Date:  2012-10-23       Impact factor: 3.630

9.  Benzodiazepine Use Is Associated With an Increased Risk of Neurocognitive Impairment in People Living With HIV.

Authors:  Rowan Saloner; David J Grelotti; Griffin Tyree; Erin E Sundermann; Qing Ma; Scott Letendre; Robert K Heaton; Mariana Cherner
Journal:  J Acquir Immune Defic Syndr       Date:  2019-12-15       Impact factor: 3.771

Review 10.  Is Long-Term Benzodiazepine Use a Risk Factor for Cognitive Decline? Results of a Systematic Review.

Authors:  Danilo Nader; Linda Gowing
Journal:  J Addict       Date:  2020-01-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.